Dodick, D.W., Turkel, C.C.,DeGryse, R.E., Aurora, S.K., Silberstein, S.D., Lipton, R.B., Diener, H.C. and Brin, M.F., PREEMPT Chronic Migraine Study Group (2010) Onabotulinumtoxin A for Treatment of Chronic Migraine: Pooled Results from the Double-Blind, Randomized, Placebo-Controlled Phases of the PREEMPT Clinical Program. Headache, 50, 921-936.
http://dx.doi.org/10.1111/j.1526-4610.2010.01678.x

has been cited by the following article:

• TITLE: OnabotulinumtoxinA in the Treatment of Occipital Neuralgia Following Gunshot Injury

  AUTHORS: Andrew Ea, Terence Gray

  KEYWORDS: Occipital Neuralgia, OnabotulinumtoxinA, Botox, Bupivacaine, Lidocaine, Gunshot

  JOURNAL NAME: Pain Studies and Treatment, Vol.4 No.4, September 7, 2016

  ABSTRACT: Occipital neuralgia, while typically idiopathic in presentation, is a common form of posttraumatic headache. It is associated with severe pain in the greater, lesser, and/or third occipital nerves, and often accompanied by tenderness or trigger points in the surrounding musculature. OnabotulinumtoxinA (ONA) has been recently utilized in nerve blocks to treat occipital neuralgia, but current literature supporting such use is scarce. We describe a case of occipital neuralgia in a patient following C1 fracture and vertebral artery dissection due to gunshot injury. Successful treatment with bilateral ONA nerve blocks led to an 80% - 90% improvement in pain, with decreased Visual Analog Scale (VAS) pain scores immediately following treatment and upon follow-up 1 month later.